Teleflex (1TFX) Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
1TFX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$118.00 |
| 52 Week High | US$114.00 |
| 52 Week Low | US$84.50 |
| Beta | 0.82 |
| 1 Month Change | 2.97% |
| 3 Month Change | 18.47% |
| 1 Year Change | 14.56% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1TFX | IT Medical Equipment | IT Market | |
|---|---|---|---|
| 7D | 7.5% | -1.2% | 1.8% |
| 1Y | 14.6% | -14.8% | 25.2% |
Return vs Industry: 1TFX exceeded the Italian Medical Equipment industry which returned -11.6% over the past year.
Return vs Market: 1TFX underperformed the Italian Market which returned 26.8% over the past year.
Price Volatility
| 1TFX volatility | |
|---|---|
| 1TFX Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in IT Market | 8.4% |
| 10% least volatile stocks in IT Market | 3.0% |
Stable Share Price: 1TFX's share price has been volatile over the past 3 months compared to the Italian market.
Volatility Over Time: 1TFX's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 15,500 | Jason Weidman | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.
Teleflex Incorporated Fundamentals Summary
| 1TFX fundamental statistics | |
|---|---|
| Market cap | €5.21b |
| Earnings (TTM) | €1.19m |
| Revenue (TTM) | €1.86b |
Is 1TFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1TFX income statement (TTM) | |
|---|---|
| Revenue | US$2.13b |
| Cost of Revenue | US$949.97m |
| Gross Profit | US$1.18b |
| Other Expenses | US$1.18b |
| Earnings | US$1.36m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.031 |
| Gross Margin | 55.33% |
| Net Profit Margin | 0.064% |
| Debt/Equity Ratio | 86.6% |
How did 1TFX perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/07 06:15 |
| End of Day Share Price | 2026/07/07 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Teleflex Incorporated is covered by 25 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Taylor | Barclays |
| Travis Steed | BofA Global Research |
| James Lucas | Brean Capital Historical (Janney Montgomery) |